REGMF (RemeGen Co) Days Payable : 148.10 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is RemeGen Co Days Payable?

RemeGen Co's average Accounts Payable for the six months ended in Jun. 2024 was $18.9 Mil. RemeGen Co's Cost of Goods Sold for the six months ended in Jun. 2024 was $23.3 Mil. Hence, RemeGen Co's Days Payable for the six months ended in Jun. 2024 was 148.10.

The historical rank and industry rank for RemeGen Co's Days Payable or its related term are showing as below:

REGMF' s Days Payable Range Over the Past 10 Years
Min: 204.3 Med: 432.75 Max: 684.28
Current: 204.3

During the past 6 years, RemeGen Co's highest Days Payable was 684.28. The lowest was 204.30. And the median was 432.75.

REGMF's Days Payable is ranked better than
61.2% of 714 companies
in the Biotechnology industry
Industry Median: 127.37 vs REGMF: 204.30

RemeGen Co's Days Payable declined from Jun. 2023 (435.37) to Jun. 2024 (148.10). It may suggest that RemeGen Co accelerated paying its suppliers.

RemeGen Co Days Payable Historical Data

The historical data trend for RemeGen Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Days Payable Chart

RemeGen Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

598.54

267.74

264.15

RemeGen Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial							176.63	342.96	435.37	242.92	148.10

Competitive Comparison of RemeGen Co's Days Payable

For the Biotechnology subindustry, RemeGen Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RemeGen Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's Days Payable distribution charts can be found below:

* The bar in red indicates where RemeGen Co's Days Payable falls into.

RemeGen Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

RemeGen Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (31.799	+	19.514)	/	2 )	/	35.452	*	365
=	25.6565					/	35.452	*	365
=	264.15

RemeGen Co's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (19.514	+	18.355)	/	2 )	/	23.332	*	365 / 2
=	18.9345					/	23.332	*	365 / 2
=	148.10

RemeGen Co Days Payable Related Terms

Thank you for viewing the detailed overview of RemeGen Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

RemeGen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (OTCPK:REGMF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

09995:Hong Kong REG:Germany 688331:China

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

https://www.remegen.com

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.